459 related articles for article (PubMed ID: 12766899)
21. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
[TBL] [Abstract][Full Text] [Related]
22. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Gd-DTPA and Gd-BOPTA for studying renal perfusion and filtration.
Notohamiprodjo M; Pedersen M; Glaser C; Helck AD; Lodemann KP; Jespersen B; Fischereder M; Reiser MF; Sourbron SP
J Magn Reson Imaging; 2011 Sep; 34(3):595-607. PubMed ID: 21761461
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
[TBL] [Abstract][Full Text] [Related]
26. [Enhanced MR-angiography (CE-MRA) of the supraaortic arteries: dose reduction with a contrast agent of high relaxivity (Gd-BOPTA)].
Friese S; Klose U; Kastrup A; Krapf H; Küker W
Rofo; 2003 Oct; 175(10):1363-7. PubMed ID: 14556105
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine.
Feuerlein S; Gupta RT; Boll DT; Merkle EM
Eur J Radiol; 2012 Sep; 81(9):2037-41. PubMed ID: 21719224
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
30. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
[TBL] [Abstract][Full Text] [Related]
32. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries.
Wikström J; Wasser MN; Pattynama PM; Bonomo L; Hamm B; Del Maschio A; Knopp MV; Marchal G; Barentsz JO; Oudkerk M; Hentrich HR; Daprà M; Kirchin MA; Shen N; Spinazzi A; Ahlström H
Invest Radiol; 2003 Aug; 38(8):504-15. PubMed ID: 12874517
[TBL] [Abstract][Full Text] [Related]
33. Safety characteristics of gadobenate dimeglumine: clinical experience from intra- and interindividual comparison studies with gadopentetate dimeglumine.
Shellock FG; Parker JR; Pirovano G; Shen N; Venetianer C; Kirchin MA; Spinazzi A
J Magn Reson Imaging; 2006 Dec; 24(6):1378-85. PubMed ID: 17078095
[TBL] [Abstract][Full Text] [Related]
34. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
[TBL] [Abstract][Full Text] [Related]
35. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
[TBL] [Abstract][Full Text] [Related]
36. Dose comparison of single- vs. double-dose in contrast-enhanced magnetic resonance angiography of the carotid arteries: Intraindividual cross-over blinded trial using Gd-DTPA.
Jourdan C; Heverhagen JT; Knopp MV
J Magn Reson Imaging; 2007 Mar; 25(3):557-63. PubMed ID: 17326082
[TBL] [Abstract][Full Text] [Related]
37. Intraindividual comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine for time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the upper torso.
Fink C; Puderbach M; Ley S; Risse F; Kuder TA; Bock M; Thaler J; Plathow C; Kauczor HU
J Magn Reson Imaging; 2005 Aug; 22(2):286-90. PubMed ID: 16028246
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
[TBL] [Abstract][Full Text] [Related]
39. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
Yrjänä SK; Vaara T; Karttunen A; Koivukangas J
Invest Radiol; 2008 Apr; 43(4):267-75. PubMed ID: 18340251
[TBL] [Abstract][Full Text] [Related]
40. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography.
Herborn CU; Lauenstein TC; Ruehm SG; Bosk S; Debatin JF; Goyen M
Invest Radiol; 2003 Jan; 38(1):27-33. PubMed ID: 12496518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
